The second update to Pharmaceutical Substances took place on May 15, 2004 and encompasses - next to extensive software amendments - the following 38 new active pharmaceutical ingredients:
Aprepitant | Arsenic trioxide | Artemotil | Bimatoprost | Colforsin dapropate | Dexmedetomidine | Drospirenone | Escitalopram oxalate | Etoricoxib | Exemestane | Ezetimibe | Frovatriptan | Fudosteine | Fulvestrant | Gefitinib | Lafutidine | Landiolol | Levocetirizine | Levosimendan | Nafarelin acetate | Neridronic acid | Nitazoxanide | Nitisinone | Olopatadine | Parecoxib sodium | Pimecrolimus | Quinupristin | Rimexolone | Rosuvastatin calcium | Sarpogrelate | Sivelestat | Tadalafil | Temoporfin | Tiotropium bromide | Travoprost | Treprostinil | Vardenafil hydrochloride | Verteporfin |
|
